Subscribe
shutterstock_1928703866_bukhta_yurii
Bukhta Yurii / Shutterstock.com
3 August 2023FeaturesBig PharmaPriscila Kashiwabara and Luan Scalzitti

Cannabis and IP: Nurturing innovation in Brazil’s life sciences industry

The cannabis industry has experienced increasing recognition, mainly due to its versatile applications. Due to the pharmaceutical properties of medical cannabis (or medical marijuana), many countries have legalised its use.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Plant Varieties
Haynes Boone launches CBD advisory practice
8 September 2021   International law firm Haynes Boone has launched the CBD Hemp Industry Group to advise businesses on the burgeoning cannabinoid market.
Plant Varieties
New York judge denies arbitration request in $881m cannabinoid suit
27 July 2021   A New York federal court has denied biotechnology company Amyris’ bid for arbitration in an $881 million trade secrets and patent infringement dispute with cannabis firm Lavvan.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Plant Varieties
Haynes Boone launches CBD advisory practice
8 September 2021   International law firm Haynes Boone has launched the CBD Hemp Industry Group to advise businesses on the burgeoning cannabinoid market.
Plant Varieties
New York judge denies arbitration request in $881m cannabinoid suit
27 July 2021   A New York federal court has denied biotechnology company Amyris’ bid for arbitration in an $881 million trade secrets and patent infringement dispute with cannabis firm Lavvan.

More on this story

Plant Varieties
Haynes Boone launches CBD advisory practice
8 September 2021   International law firm Haynes Boone has launched the CBD Hemp Industry Group to advise businesses on the burgeoning cannabinoid market.
Plant Varieties
New York judge denies arbitration request in $881m cannabinoid suit
27 July 2021   A New York federal court has denied biotechnology company Amyris’ bid for arbitration in an $881 million trade secrets and patent infringement dispute with cannabis firm Lavvan.

More features

China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
Sanofi subsidiary fends off $450m trade secrets case
Teva faces $500m fine for antitrust breaches over MS drug
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar